Cloning of mouse γ-glutamyl hydrolase in the form of two cDNA variants with different 5' ends and encoding alternate leader peptide sequences

Gene

Volumn 219, Issue 1-2, 1998, Pages 37-44

  Esaki, Taito ^a   Roy, Krishnendu ^a   Yao, Rong ^b   Galivan, John ^b   Sirotnak, F M ^a,c  

^a Program in Molecular Pharmacology   (United States)

^b WADSWORTH CENTER   (United States)

^c Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

glutamyl hydrolase; Alternate 5' ends and leader peptides

Indexed keywords

ASPARAGINE; COMPLEMENTARY DNA; CYSTEINE; GAMMA GLUTAMYL HYDROLASE; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; GENETIC HETEROGENEITY; KIDNEY; LUNG; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RNA ANALYSIS; SALIVARY GLAND; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; SMALL INTESTINE; SPLEEN; STOMACH; THYMUS; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; GAMMA-GLUTAMYL HYDROLASE; HUMANS; LIVER; LYSOSOMES; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN SORTING SIGNALS; RATS; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

ANIMALIA; RODENTIA;

EID: 0032575875     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00384-9     Document Type: Article

References (33)

1. Badley J.E., Bishop G.A., St. John T., Frelinger J.A. A simple, rapid method for the purification of poly A+ RNA. Biotechniques. 6:1988;114-116.
2. Barrueco, J.R., Sirotnak, F.M., 1989. Lysosomal permeability to methotrexate polyglutamates. In: Curtius, H.-Ch., Ghisla, S., Blau, N. (Eds.), Chemistry and Biology of Pteridines. Walter de Gruyter, New York, pp. 1253-1256.
3. Barrueco J.R., O'Leary D.F., Sirotnak F.M. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds. J. Biol. Chem. 267:1992;15356-15361.
4. Bhandari S.D., Gregory J.F., Renuart D.R., Merritt A.M. Properties of pteroylpolyglutamate hydrolase in pancreatic juice of the pig. J. Nutr. 120:1990;467-475.
5. Chandler C.J., Wang T.T., Halsted C.H. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterization. J. Biol. Chem. 261:1986;928-933.
6. Elsenhans B., Ahmad O., Rosenberg I.H. Isolation and characterization of pteroylpolyglutamate hydrolase from rat intestinal mucosa. J. Biol. Chem. 259:1984;6364-6368.
7. Fabre I., Fabre G., Goldman I.D. Polyglutamylation, and important element in methotrexate cytoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Cancer Res. 44:1984;3190-3195.
8. Hedrick S.M., Cohen D.I., Nielsen E.A., Davis M.M. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature. 308:1984;149-153.
9. Kisliuk R.L. Pteroylpolyglutamates. Mol. Cell. Biochem. 39:1981;331-345.
10. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:1987;8125-8148.
11. Lyko F., Martoglio B., Jungnickel B., Rapoport T.A., Dobberstein B. Signal sequence processing in rough microsomes. J. Biol. Chem. 270:1995;19873-19878.
12. McCloskey D.E., McGuire J.J., Russell C.A., Rowan B.G., Bertino J.R., Pizzorno G., Mini E. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. J. Biol. Chem. 226:1991;6181-6187.
13. McGuire, J.J., Coward, J.K., 1984. Pteroylpolyglutamates: biosynthesis, degradation, and function. In: Blakley, R.L., Benkovic, S.J. (Eds.), Folates and Pterins. Wiley Interscience, New York, Vol. 1, pp. 135-190.
14. Moran R.G., Colman P.D. Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enzyme. Biochemistry. 23:1984;4580-4589.
15. Moran R.G., Colman P.D., Rosowsky A., Forsch R.A., Chan K.K. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase. Mol. Pharmacol. 27:1985;156-166.
16. O'Connor B.M., Rotundo R.F., Nimec Z., McGuire J.J., Galivan J. Secretion of gamma-glutamyl hydrolase in vitro. Cancer Res. 51:1991;3874-3881.
17. Pizzorno G., Moroson B.A., Cashmore A.R., Russello O., Mayer J.R., Galivan J., Bunni M.A., Priest D.G., Beardsley G.P. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Cancer Res. 55:1995;566-573.
18. Rhee M.S., Wang Y., Nair M.G., Galivan J. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Cancer Res. 53:1995;2227-2230.
19. Rhee M.S., Ryan T.J., Galivan J.H. γ-Glutamyl hydrolase secreted from human tumor cell lines. Cell. Pharmacol. 2:1995;289-292.
20. Roy K., Egan M.G., Sirlin S., Sirotnak F.M. Posttranscriptionally mediated decreases in folypolyglutamate synthetase gene expression in some folate analogue-resistant variants of the L1210 cell. J. Biol. Chem. 272:1997;6903-6908.
21. Roy K., Mitsugi K., Sirlin S., Shane B., Sirotnak F.M. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription. J. Biol. Chem. 270:1995;26918-26922.
22. Rumberger B.G., Barrueco J.R., Sirotnak F.M. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Cancer Res. 50:1990;4639-4643.
23. Rumberger B.G., Schmid F.A., Otter G.M., Sirotnak F.M. Preferential selection during therapy in vivo by edatrexate compared to methotrexate of resistant L1210 cell variants with decreased folylpolyglutamate synthetase activity. Cancer Commun. 2:1990;305-310.
24. Samuels L.L., Moccio D.M., Sirotnak F.M. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro. Cancer Res. 45:1985;1488-1495.
25. Samuels L.L., Goutas L.J., Priest D.G., Piper J.R., Sirotnak F.M. Hydrolytic cleavage of methotrexate γ-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. Cancer Res. 46:1986;2230-2235.
26. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
27. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam. Horm. 45:1989;263-335.
28. Sirotnak, F.M., DeGraw, J.I., 1984. Selective antitumor action of folate analogs. In: Sirotnak, F.M., Burchall, J.J., Ensminger, W.D., Montgomery, J.A. (Eds.), Folate Antagonists as Therapeutic Agents. Academic Press, New York, Vol. 2, pp. 43-91.
29. Wang Y., Nimec Z., Ryan T.J., Dias J.A., Galivan J. The properties of the secreted gamma-glutamyl hydrolases from H35 hepatoma cells. Biochim. Biophys. Acta. 1164:1993;227-235.
30. Winzler, R.J., 1973. The chemistry of glycoproteins. In: Li, C.H. (Ed.), Hormonal Proteins and Peptides. Academic Press, New York, pp. 1-15.
31. Yao R., Rhee M., Galivan J. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells. Mol. Pharmacol. 48:1995;505-511.
32. Yao R., Nimec Z., Ryan T.J., Galivan J. Identification, cloning, and sequencing of a cDNA coding for rat gamma-glutamyl hydrolase. J. Biol. Chem. 271:1996;8525-8528.
33. Yao R., Schneider E., Ryan T.J., Galivan J. Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. Proc. Natl. Acad. Sci. USA. 93:1996;10134-10138.